Full-Time

Business Operations Manager

Scientific Department

Posted on 11/15/2024

Celerion

Celerion

1,001-5,000 employees

Clinical research organization for drug development

Biotechnology
Healthcare

Junior, Mid

Lincoln, NE, USA

Hybrid position in Lincoln, NE.

Category
Project Management
Business Development
Operations & Logistics
Business & Strategy
Requirements
  • Bachelor’s degree in Business, Life Sciences or related field required.
  • Scientific background preferred
  • Requires high-level skills in the areas of strategic thinking, organization, multi-tasking, relationship-building, communication, judgment, problem-solving, persuading and negotiating.
  • Minimum 2 years industry experience, or equivalent, required.
  • 3 years project team experience preferred.
  • Business management experience desired
Responsibilities
  • Develops and clarifies DMB project scope in conjunction with Global Project Managers (GPM), client, and internal team.
  • Reviews the DMB fee and ensures it accurately reflects project scope and communicates this to the team members responsible for providing the deliverables to clients
  • Works with GPM, assigned DBM team members, and functional managers in the development, assignment and prioritization of work based on the project’s needs and individual’s developmental needs. Coaches DMB team members as necessary to ensure successful project deliverables.
  • Manages multiple DMB projects for clients.
  • Works with GPM and DMB project team members to establish priority for awarded work to meet contracted deadlines - takes corrective action to control project timelines
  • Holds DMB project team members accountable for delivering on project scope & timelines.
  • Schedules and leads regular DMB project team meetings throughout the progress of a project to keep the team engaged and to keep the project on track with client expectations.
  • Proactively takes action to ensure the DMB project stays on target through the use of day to day monitoring of projects, schedules and project staff while considering downstream impact of upstream actions.
  • Ensures adherence to contracted Terms and Conditions and proactively communicates to team members
  • Drives monthly DMB revenue by making project work priority decisions
  • Works with DMB team members to build client relationships that results in additional business
  • Maintains performance metrics for appropriate DBM deliverables
  • Implements changes when appropriate to remove bottlenecks, improve processes and procedures and improve the efficiency and effectiveness of the organization.
  • Updates correct databases, generates required reports on projects to meet and summarizes data for month-end reports as required.

Celerion specializes in early phase drug development as a clinical research organization (CRO). The company provides a range of services to pharmaceutical and biotechnology companies, including clinical trial design, feasibility studies, project management, and regulatory affairs. Celerion uses advanced bioanalytical techniques, particularly High Resolution Mass Spectrometry (HR MS), for metabolite profiling and identification, which enhances their research capabilities. This focus on bioanalytical sciences and their extensive experience allows Celerion to assist clients in making informed decisions during the early stages of drug development. Unlike many competitors, Celerion emphasizes speed and quality in their research processes, aiming to help clients bring new treatments to market more quickly, ultimately benefiting patients around the world.

Company Stage

Acquired

Total Funding

N/A

Headquarters

Lincoln, Nebraska

Founded

N/A

Growth & Insights
Headcount

6 month growth

11%

1 year growth

11%

2 year growth

13%
Simplify Jobs

Simplify's Take

What believers are saying

  • Celerion's expansion into GLP/GCP compliant molecular and cell biology testing positions it well to support the growing field of cell and gene therapies.
  • The appointment of Jo Goodman as VP of Bioanalytical Services brings extensive industry experience, potentially driving innovation and enhancing service delivery.
  • H.I.G. Capital's acquisition of Celerion could provide additional resources and strategic direction, fostering further growth and development.

What critics are saying

  • The acquisition by H.I.G. Capital may lead to changes in company culture or strategic priorities, potentially causing uncertainty among employees.
  • The competitive landscape of CROs requires Celerion to continuously innovate and maintain high standards to retain its leadership position.

What makes Celerion unique

  • Celerion's expertise in early phase drug development and advanced bioanalytical sciences, particularly in metabolite profiling using HR MS, sets it apart from other CROs.
  • The company's consistent recognition with CRO Leadership Awards highlights its reputation for quality, capabilities, and reliability in the industry.
  • Celerion's recent CLIA certification enhances its bioanalytical laboratory capabilities, allowing it to conduct high-complexity testing and diagnostic services.

Help us improve and share your feedback! Did you find this helpful?